EpitogenX aims to revolutionise diagnostics through innovative technology and deep collaboration with academic and clinical partners.

Deborah O’Neil, chair of the ONE Life Sciences and BioAberdeen responds to the Sunday Times’ article. Last week, think tank Our Scottish Future published a report – “Innovation Nation: Good Jobs for Scotland’s Future”. It was positioned as a Scottish industrial strategy, anchored by innovation-led growth and identified life sciences as a sectoral strength for Scotland. If Scotland is serious about building the future economy, it needs to look north.

Through strong leadership, customer-centric growth, and a long-term vision for R&D, NCIMB is poised to deliver microbial solutions that address some of society’s biggest challenges—from decarbonisation to healthy living.